1-6 of 6
Joseph Norton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II clinical trial of bortezomib in combination with CPX-351 for the treatment of newly-diagnosed TP53-mutated Acute Myeloid Leukemia (NCT07008638)

Free
Joseph Norton, Nuttavut Sumransub, Kieth Cordner, Jeremy Allred, Naveen Premnath, Sean Tracy, Craig Eckfeldt, Qing Cao, Mark Juckett, Veronika Bachanova, Zohar Sachs
Journal: Blood
Blood (2025) 146 (Supplement 1): 3433.
https://doi.org/10.1182/blood-2025-3433
Published: 2025
Journal Articles

Allogeneic hematopoietic stem cell transplantation for hematological malignancies using nonmyeloablative fludarabine, cyclophosphamide, 200 centigray total body irradiation, and post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil for graft-versus-host disease prophylaxis is associated with low non-relapse mortality.

Free
Christopher Graham, Roy Kao, Qing Cao, Punita Grover, Joseph Norton, Cameron McDonald-Hyman, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 4220.
https://doi.org/10.1182/blood-2025-4220
Published: 2025
Journal Articles

Coronary artery calcification and its effect on cardiac events in patients undergoing allogeneic stem cell transplantation using nonmyeloablative conditioning

Free
Christopher Graham, Roy Kao, Qing Cao, Cameron McDonald-Hyman, Joseph Norton, Punita Grover, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 4219.
https://doi.org/10.1182/blood-2025-4219
Published: 2025
Journal Articles

Risk of relapse and mortality after non-myeloablative allogeneic stem cell transplant for Acute Myeloid Leukemia and myelodysplastic syndrome after fludarabine, cyclophosphamide, and 200 centigray total body irradiation  with gvhd prophylaxis using post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil: Impact of maintenance chemotherapy

Free
Christopher Graham, Roy Kao, Qing Cao, Cameron McDonald-Hyman, Joseph Norton, Punita Grover, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 7781.
https://doi.org/10.1182/blood-2025-7781
Published: 2025
Journal Articles

Gtb-3650 (anti-CD16/IL-15/anti-CD33) tri-specific killer engager (TriKE®) for the treatment of high risk myelodysplastic syndromes (MDS) and refractory/relapsed (R/R) Acute Myeloid Leukemia (AML) (NCT06594445)

Free
Mark Juckett, Christopher Graham, Punita Grover, Joseph Norton, Naveen Premnath, Craig Eckfeldt, Zohar Sachs, Cassie Seichter, Andrea Hoeschen, Cameron McDonald-Hyman, Jeremy Allred, Rose Wangen, Martin Felices, Jeffrey Miller
Journal: Blood
Blood (2025) 146 (Supplement 1): 6947.
https://doi.org/10.1182/blood-2025-6947
Published: 2025
Journal Articles

In Vivo Potency of Hematopoietic Stem Cells after Long-Term Storage at -80C in DMSO+HES Cryprotectant Mixture: Comparing Engraftment Kinetics and Efficacy Data in First and Second Autologous Stem Cell Transplantation in Myeloma

Free
Joseph Norton, Loredana Campo, Patrick Hagen, Stephanie B. Tsai, Patrick J. Stiff
Journal: Blood
Blood (2023) 142 (Supplement 1): 6779.
https://doi.org/10.1182/blood-2023-182191
Published: 2023